NEW YORK, June 27, 2016 /PRNewswire/ -- Harwood Feffer
LLP (www.hfesq.com) is investigating potential claims against the
board of directors of HeartWare International, Inc. ("HeartWare" or
the "Company") (NASDAQ: HTWR) concerning the proposed acquisition
of the Company by Medtronic, Inc. ("Medtronic").
Under the terms of the offer, Medtronic would acquire HeartWare
in a transaction valued at approximately $1.1 billion. Pursuant to the deal,
HeartWare stockholders will be offered $58 per share in cash. At least one Wall
Street analyst has set a target price for HeartWare stock of
$60.00 per share.
Our investigation concerns whether the HeartWare board of
directors is fulfilling its fiduciary duties, maximizing the value
of the Company, disclosing all material benefits and costs, and
obtaining full and fair consideration for Company
stockholders.
If you own HeartWare shares and wish to discuss this matter with
us, or have any questions concerning your rights and interests with
regard to this matter, please contact:
Benjamin I. Sachs-Michaels,
Esq.
Robert I. Harwood, Esq.
Harwood Feffer LLP
488 Madison Avenue
New York, New York 10022
Phone Numbers: (877) 935-7400
(212)935-7400
Email: bsachsmichaels@hfesq.com
Website: http://www.hfesq.com
Follow us on Twitter: @HarwoodFeffer
Harwood Feffer has been
representing individual and institutional investors for many years,
serving as lead counsel in numerous cases in federal and state
courts. Please visit the Harwood Feffer LLP website
(http://www.hfesq.com) for more information about the firm.
Attorney Advertising. The law firm responsible for this
advertisement is Harwood Feffer LLP (www.hfesq.com). Prior results
do not guarantee or predict a similar outcome with respect to any
future matter.
Logo -
http://photos.prnewswire.com/prnh/20120215/MM54604LOGO
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/harwood-feffer-llp-announces-investigation-of-heartware-international-inc-300290710.html
SOURCE Harwood Feffer LLP
